Literature DB >> 15016837

Interrelationship of growth differentiation factor 9 and inhibin in early folliculogenesis and ovarian tumorigenesis in mice.

Xuemei Wu1, Lei Chen, Christopher A Brown, Changning Yan, Martin M Matzuk.   

Abstract

To investigate the interrelationship of inhibin alpha and growth differentiation factor 9 (GDF9) during early folliculogenesis, we generated mice lacking both inhibin alpha and GDF9. Our findings on these Inha Gdf9 double-mutant mice are as follows: 1). females develop ovarian tumors and a cachexia-like wasting syndrome, resembling mice lacking inhibin alpha alone. This indicates that the granulosa cells are competent to proliferate despite the lack of GDF9; 2). follicular development progresses to multiple-layer follicle stages before tumorigenesis. This demonstrates that the up-regulation of inhibin alpha in the Gdf9 knockout ovary directly prevents the proliferation of the granulosa cells at the primary follicle stage, an effect that is released in the absence of inhibin alpha; 3). a morphological theca forms around the preantral follicles with no detectable selective theca markers [i.e. 17alpha-hydroxylase (Cyp17), LH receptor (Lhr), and Kit]. These results indicate that the theca recruitment can occur independently of GDF9, but the differentiation of thecal cells is blocked; and 4). inhibin/activin subunits betaA, betaB, and Kit ligand (Kitl) mRNA are highly up-regulated, suggesting that the increased activins and KITL play functional roles in early folliculogenesis. Thus, GDF9 appears to function indirectly to regulate early granulosa cell proliferation and theca recruitment in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15016837     DOI: 10.1210/me.2003-0399

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  20 in total

1.  Loss of inhibin alpha uncouples oocyte-granulosa cell dynamics and disrupts postnatal folliculogenesis.

Authors:  Michelle Myers; Brooke S Middlebrook; Martin M Matzuk; Stephanie A Pangas
Journal:  Dev Biol       Date:  2009-08-08       Impact factor: 3.582

Review 2.  The mammalian ovary from genesis to revelation.

Authors:  Mark A Edson; Ankur K Nagaraja; Martin M Matzuk
Journal:  Endocr Rev       Date:  2009-09-23       Impact factor: 19.871

3.  WEE2 is an oocyte-specific meiosis inhibitor in rhesus macaque monkeys.

Authors:  Carol B Hanna; Shan Yao; Maristela C Patta; Jeffrey T Jensen; Xuemei Wu
Journal:  Biol Reprod       Date:  2010-03-03       Impact factor: 4.285

Review 4.  The TGF-β Family in the Reproductive Tract.

Authors:  Diana Monsivais; Martin M Matzuk; Stephanie A Pangas
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-10-03       Impact factor: 10.005

Review 5.  Activins and Inhibins: Roles in Development, Physiology, and Disease.

Authors:  Maria Namwanje; Chester W Brown
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-07-01       Impact factor: 10.005

Review 6.  The function of bone morphogenetic proteins in the human ovary.

Authors:  Osamu Yoshino; Jia Shi; Yutaka Osuga; Miyuki Harada; Osamu Nishii; Tetsu Yano; Yuji Taketani
Journal:  Reprod Med Biol       Date:  2011-01-06

Review 7.  New insights into ovarian function.

Authors:  Joanne S Richards; Stephanie A Pangas
Journal:  Handb Exp Pharmacol       Date:  2010

8.  GDF9 modulates the reproductive and tumor phenotype of female inha-null mice.

Authors:  Michelle Myers; Nadera Mansouri-Attia; Rebecca James; Jia Peng; Stephanie A Pangas
Journal:  Biol Reprod       Date:  2013-04-04       Impact factor: 4.285

9.  Systematic analysis, comparison, and integration of disease based human genetic association data and mouse genetic phenotypic information.

Authors:  Yonqing Zhang; Supriyo De; John R Garner; Kirstin Smith; S Alex Wang; Kevin G Becker
Journal:  BMC Med Genomics       Date:  2010-01-21       Impact factor: 3.063

10.  Oocyte-granulosa-theca cell interactions during preantral follicular development.

Authors:  Makoto Orisaka; Kimihisa Tajima; Benjamin K Tsang; Fumikazu Kotsuji
Journal:  J Ovarian Res       Date:  2009-07-09       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.